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Abstract
The benefits of therapeutic hypothermia (TH) in severe traumatic brain injury (sTBI) have been long de-
bated. In 2018, the POLAR study, a high-quality international trial, appeared to end the debate by showing
that TH did not improve mortality in sTBI. However, the POLAR-based recommendation to abandon TH was
challenged by different investigators. In our recent meta-analysis, we introduced the cooling index (COIN)
to assess the extent of cooling and showed that TH is beneficial in sTBI, but only when the COIN is suffi-
ciently high. In the present study, we calculated the COIN for the POLAR study and ran a new meta-analysis,
which included the POLAR data and accounted for the cooling extent. The POLAR study targeted a high
cooling extent (COIN of 276C · h; calculated for 72 h), but the achieved cooling was much lower (COIN
of 193C · h)—because of deviations from the protocol. When the POLAR data were included in the
COIN-based meta-analysis, TH had an overall effect of reducing death (odds rate of 0.686; p = 0.007).
Among the subgroups with different COIN levels, the only significantly decreased odds rate (i.e., beneficial
effect of TH) was observed in the subgroup with high COIN (0.470; p = 0.013). We conclude that, because of
deviations from the targeted cooling protocol, the overall cooling extent was not sufficiently high in the
POLAR study, thus masking the beneficial effects of TH. The current analysis shows that TH is beneficial
in sTBI, but only when the COIN is high. Abandoning the use of TH in sTBI may be premature.
Keywords: cooling index; induced hypothermia; meta-analysis; mortality; thermoregulation; traumatic brain
injury
Introduction
The usefulness of therapeutic hypothermia (TH) in severe
traumatic brain injury (sTBI) has been long debated. In
December 2018, the Prophylactic Hypothermia Trial to
Lessen Traumatic Brain Injury (POLAR), a multi-center
randomized controlled trial, appeared to end the debate
by showing that TH did not improve the outcomes,
including death rates, in sTBI.1 However, the POLAR-
based recommendation to abandon TH was challenged.2–4
It was especially difficult to achieve consensus regarding
the use of moderate TH (deep body temperature <35C),
given that 24 of the 35 surveyed experts stated that it
had a role in the treatment of sTBI with elevated intracra-
nial pressure (Seattle International sTBI Consensus Con-
ference, Survey 3).5 After several rounds of voting, the
routine use of moderate TH was not recommended,
whereas mild TH was recommended, but only as tier-
three treatment.5,6
In our recent meta-analysis,7 we introduced the cool-
ing index (COIN) to quantify the extent of TH in sTBI
and showed that TH was beneficial only when the
COIN was high. Our results suggested that the COIN
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(as a measure of the magnitude of hypothermia) is an im-
portant factor in the effectiveness of TH, given that the
effect of cooling on neuroprotection can depend on its
overall extent determined by depth, duration, and
rewarming rate. Could it be that the overall COIN was
not sufficiently high in POLAR, thus masking the true po-
tential of TH and limiting its use? To test this hypothesis,
we ran a new meta-analysis, which included the POLAR
data and accounted for the extent of TH.
Methods
After confirming, through the quality assessment proto-
col,7 that the POLAR study met the criteria for high-
quality trials (a high level of randomization), we
extracted the targeted cooling parameters (viz., cooling
temperature, cooling duration, and speed of rewarming),
accounted for any deviations from or adjustments to
them, and calculated the COIN values (see Table 1 for
the formula). Based on the COIN, we included the
death rates (assessed as odds ratio [OR]) reported by
POLAR in the appropriate subgroup of the COIN-based
meta-analysis, as described in details previously,7 and
formally analyzed this new, extended data set, which in-
cluded data from 13 studies.1,8–19
Publication bias was assessed with funnel plots by
using the trim-and-fill method20 and the test by Egger
and colleagues21 (see Supplementary Fig. S1). Egger’s
test values <0.1 were considered as indicators of a signif-
icant small-study effect. Between-study heterogeneity
was tested with the Q homogeneity test ( p values <0.05
were considered as indicators of significant heterogene-
ity) and with the I2 statistical test, where I2 is the propor-
tion of total variation attributable to between-study
variability (an I2 value >50% was considered as indicat-
ing considerable heterogeneity).
Results
The COIN value would have been high in the POLAR
study—if the targeted parameters (Table 1) were met.
However, the targeted cooling parameters were reached
in less than one half of patients receiving TH (Table 1).
In the hypothermia group, 85 patients (33%) were cooled
for <48 h; 27 patients (10%) never reached a deep body
temperature of 35C; and 65 patients (27%) never
reached 33C.1 Hence, many patients in the POLAR
study had a low level of COIN, and the overall level
achieved in that study was only moderate (Table 1).
Based on the above, we included the POLAR data in
the ‘‘Moderate’’ COIN subgroup of our meta-analysis
(Fig. 1). For all data, including POLAR, the OR for
death was 0.686 ( p = 0.007), indicating that, overall,
TH significantly decreased mortality in sTBI. However,
a significant decrease in OR (indicating a beneficial effect
of TH) was observed only in the ‘‘High’’ COIN subgroup
(0.470; p = 0.013). ORs in subgroups with ‘‘Low’’ or
‘‘Moderate’’ cooling intensity were 0.718 ( p = 0.081)
and 0.846 ( p = 0.533), respectively.
Between-study heterogeneity was relatively small,
as indicated by the Q homogeneity test (Q = 19.1;
p = 0.085) and the I2 statistical test (I2 = 37.3%). Neither
of the used assessment methods indicated the presence
of publication bias (Supplementary Fig. S1).
Discussion
Including the POLAR results in our COIN-based meta-
analysis strengthened our former conclusion that TH
has a significant beneficial effect on death rate in sTBI,
but only when COIN is sufficiently high. The benefits
of TH were also shown in the recent review by Moore
and colleagues.22 The authors applied the umbrella re-
view methodology to several potentially low-value clini-
cal practices and found that TH was the only one with
evidence of benefit. However, the POLAR study was
not included in any of the systematic reviews analyzed
in the umbrella review by Moore and colleagues.22
When the results of POLAR were translated into
treatment guidelines preceding the present work,5,6 the ab-
sence of an overall beneficial effect led to the recommen-
dation to reduce the use of TH in sTBI. However, some
deviations from the cooling protocol occurred at different
POLAR-participating centers and decreased the overall
extent of cooling from ‘‘High’’ (targeted) to ‘‘Moderate’’
(overall achieved) and even ‘‘Low’’ (observed in many pa-
tients). This decrease in the COIN was likely to mask the
benefits of TH in the overall cohort. It would be desirable
to analyze separately the outcomes in those patients who
fully met the targeted cooling criteria and those who did
not. Until such results are available from the POLAR
group or obtained in other high-quality trial(s), it may be
premature to abandon the use of TH in sTBI.






rate (C/h) No. of patients [%] COINa (C · h) COIN subgroup
Targeted parameters 72£ 33.0 – 0.5 £0.25 260 [100] 276 High
Cooling compliance criteria 48£ £35 £0.25 124–125 [48] 77 Low
Sensitivity analysis criteria *72 £35 £0.25 120–121 [46] 112 Low
Overall study parameters 72.2 33–35 £0.25 124 [48] 193 Moderate
aCOIN =DT · t + (DT ·DT/R)/2, where DT is the difference between normal deep body temperature (36.5C) and the temperature reached at the end of
cooling (in C); ‘‘t’’ is hypothermia duration (in hours); and ‘‘R’’ is the rate of rewarming (in C/h).
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Our meta-analysis included four multi-center random-
ized controlled trials,1,9,10,14 whereas the remaining nine
studies were single-center randomized controlled tri-
als.8,11–13,15–19 It should be mentioned that intervention
effects for binary outcomes (such as mortality) were
shown to be, on average, larger in single-center random-
ized controlled trials than in multi-center trials.23 With
regard to TH, some differences between results from
single-center versus multi-center trials were noticed pre-
viously.24 The differences were explained by the diffi-
culty of keeping all parameters that influence the
outcome constant across the centers in multi-center trials.
Indeed, several significant intercenter differences (e.g., in
disease severity, drug selection, drug doses, and person-
nel experience) were found in a careful analysis of a
multi-center trial.24
In our earlier report,7 we noted that large multi-center
trials are often considered to have higher quality than
single-center trials when pharmacological treatments
are investigated. When a complex intervention is in-
volved, and the precise execution of this intervention is
crucial (as in the case of TH), then different protocols
used in different centers can lead to heterogeneous re-
sults, which can mask the differences between the treated
and control groups. It should be also mentioned that the
adherence to the TH protocol, including all the surround-
ing management, can be more closely monitored and con-
trolled in single-center studies than in large multi-center
randomized trials.
Given that positive results of single-center trials were
occasionally contradicted when tested in multi-center set-
tings, some authors concluded that physicians should
apply the findings of single-center trials only after careful
evaluation of their methodology.25 It should be also
noted, however, that the only way to avoid publication
bias is to base meta-analyses on as complete collections
of studies as possible.26 Publication bias (i.e., the possi-
bility of missing studies) must be always addressed
FIG. 1. Forest plot of the effects of therapeutic hypothermia on mortality in patients with severe traumatic
brain injury. The odds ratio was calculated by dividing the odds of death to survival in the therapeutic
hypothermia group with the odds of death to survival in the normothermia group. A ratio <1 indicates that
therapeutic hypothermia reduced the odds of death, whereas a ratio >1 indicates increased odds of death in
therapeutic hypothermia. The odds ratios were compared by using a random-effects model in high-quality,
randomized controlled trials divided into ‘‘Low’’ (<160C · h), ‘‘Moderate’’ (160C–200C · h), and ‘‘High’’
(>200C · h) subgroups based on the cooling index (COIN). All new data compared to our previous analysis7
are highlighted in red. Note that the POLAR study (Cooper and colleagues 2018)1 is included in the
‘‘Moderate’’ COIN subgroup (for details, see Table 1). aFull references to the analyzed studies can be found in
the list of references. CI, confidence interval. Color image is available online.
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according to the PRISMA guidelines,27 which were fol-
lowed in our study. In our original review protocol (reg-
istration no.: CRD42017056535), we aimed at including
all available studies in the meta-analysis, without limita-
tions to the study type—in order to achieve the most com-
prehensive review of the topic and avoid publication bias.
This approach produced a heterogeneous set of trials with
regard to both clinical and statistical designs. To reduce
the heterogeneity, we used a novel approach: We ex-
tended the conventional study selection protocols by
the detailed evaluation of statistical, clinical, and meth-
odological design aspects.7
As a result, we identified a group of 12 studies that
were homogenous with regard to all three design aspects.
Importantly, the POLAR study also fulfilled the inclusion
criteria and did not increase heterogeneity in the present
analysis. Moreover, the presence of any sizable publica-
tion bias was successfully avoided (Supplementary
Fig. S1). Based on the above, we believe that the inclu-
sion of both single-center and multi-center studies in
our analysis is justified: This is the only way to conduct
the most extensive analysis of the available data while
minimizing the risk of publication bias.
Conclusion
In conclusion, including the POLAR study in our COIN-
based meta-analysis suggests that the COIN should be
flipped again to settle the dispute on the use of TH in
sTBI.
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